DIA 2017 Annual Meeting

Component Type: Session
Level: Intermediate
CE: ACPE 1.25 Knowledge UAN: 0286-0000-17-521-L04-P; CME 1.25; IACET 1.25; RN 1.25

Many in industry are interested in identifying new and innovative technologies to engage with patients throughout and after a clinical trial. The industry is enamored with multimedia eConsent platforms, but do they really help speed clinical trials to completion and reduce regulatory burden? When patients receive patient diaries, digital data capture tools, or even digital patient stipends does the learning curve and maintenance of use really benefit the patient? When sites have to log into multiple platforms to obtain study related information, it might require a new password for each platform. A more connected world enabled by digital technology can potentially help open up conversations in the area of clinical research, but it can also create more burden for investigator sites and patients when it is not streamlined or integrated. This session will explore how these innovations are being implemented without adding burden to the sites and patient users. Speakers will discuss how they are innovative but also reducing the added burden onto the site or patient.

Learning Objectives

Recognize how to anticipate site and patient burden due to the increased trend of introducing new technology processes; Describe ways to address site and patient burden.

Chair

Deborah Howe

Speaker

How Appropriate use of Technology can Share and Reduce the Burden of Modern Clinical Trials
Paul O'Donohoe, MSc

Patient Perspective
Deborah E. Collyar